bullish
China Optimized COVID Policy and Possible Reopen Timeline
275 Views14 Nov 2022 08:48
There’re many fake news about China’s COVID policy/reopen timeline. We think it necessary to discuss the situation and establish a rational expectation.We advise investors to see the essence of things
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Xi-Biden Meeting and G20 - A Temporary Respite?16 Nov 2022
- Micro-Tech Nanjing (688029.CH)-Worth a Spot on the Watch List Due to Possibility of Dilemma Reversal16 Nov 2022
- Hutchison China MediTech (HCM.US/13.HK) - The Pain Points Become More Pronounced15 Nov 2022
- China Optimized COVID Policy and Possible Reopen Timeline14 Nov 2022
- 2023 High Conviction - China Healthcare: Recognize the Direction and Follow the Trend08 Nov 2022
- CanSino Biologics (6185.HK/688185.CH) - Time to Offload; the Rally May Not Last Long03 Nov 2022
- The Future Directions of A-Share After the 20th National Congress of the CPC03 Nov 2022
x